{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:04:51Z","timestamp":1793124291603,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Leonard Wolfson Experimental Neurology Centre"},{"name":"Alzheimer\u2019s Research UK Senior Fellowship"},{"name":"Department of Health\u2019s NIHR Biomedical Research Centres"},{"name":"NIHR Queen Square Dementia Biomedical Research Unit"},{"name":"Reta Lila Weston Institute for Neurological Studies"},{"name":"Progressive Supranuclear Palsy (Europe) Association"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40478-018-0535-z","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T04:11:28Z","timestamp":1525147888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias"],"prefix":"10.1186","volume":"6","author":[{"given":"Melissa C.","family":"Wren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammaryn","family":"Lashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"\u00c5rstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-7577","authenticated-orcid":false,"given":"Kerstin","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,1]]},"reference":[{"key":"535_CR1","doi-asserted-by":"publisher","unstructured":"Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42(3):631\u2013639. \n                    https:\/\/doi.org\/10.1212\/WNL.42.3.631","DOI":"10.1212\/WNL.42.3.631"},{"issue":"12","key":"535_CR2","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/acn3.366","volume":"3","author":"WRB Bevan Jones","year":"2016","unstructured":"Bevan Jones WRB, Cope TE, Passamonti L, Fryer TD, Hong YT, Aigbirhio F, Kril JJ, Forrest SL, Allinson K, Coles JP, Jones PS, Spillantini MG, Hodges JR, O\u2019Brien JT, Rowe JB (2016) [18F]AV-1451 PET in behavioural variant frontotemporal dementia due to MAPT mutation. Ann Clin Transl Neurol 3(12):940\u2013947 \n                    https:\/\/doi.org\/10.1002\/acn3.366","journal-title":"Ann Clin Transl Neurol"},{"key":"535_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ymeth.2017.08.003","volume":"130","author":"GN Bischof","year":"2017","unstructured":"Bischof GN, Endepols H, van Eimeren T, Drzezga A (2017) Tau-imaging in neurodegeneration. Methods 130:114\u2013123 \n                    https:\/\/doi.org\/10.1016\/j.ymeth.2017.08.003","journal-title":"Methods"},{"issue":"4","key":"535_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239\u2013259 \n                    https:\/\/doi.org\/10.1007\/BF00308809","journal-title":"Acta Neuropathol"},{"issue":"3","key":"535_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0197-4580(94)90032-9","volume":"15","author":"H Braak","year":"1994","unstructured":"Braak H, Braak E (1994) Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder. Neurobiol Aging 15(3):355\u2013356 \n                    https:\/\/doi.org\/10.1016\/0197-4580(94)90032-9","journal-title":"Neurobiol Aging"},{"issue":"7","key":"535_CR6","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1021\/acschemneuro.6b00051","volume":"7","author":"L Cai","year":"2016","unstructured":"Cai L, Qu B, Hurtle BT, Dadiboyena S, Diaz-Arrastia R, Pike VW (2016) Candidate PET radioligand development for neurofibrillary tangles: two distinct radioligand binding sites identified in postmortem Alzheimer's disease brain. ACS Chem Neurosci 7(7):897\u2013911 \n                    https:\/\/doi.org\/10.1021\/acschemneuro.6b00051","journal-title":"ACS Chem Neurosci"},{"key":"535_CR7","doi-asserted-by":"publisher","unstructured":"Castillo-Carranza DL, Guerrero-Mu\u00f1oz MJ, Sengupta U, Gerson JE (in press) Kayed R (2018) \u03b1-Synuclein oligomers induce a unique toxic tau strain. Biol Psychiatry \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2017.12.018","DOI":"10.1016\/j.biopsych.2017.12.018"},{"key":"535_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/9781444341256.ch15","volume-title":"Neurodegeneration: the molecular pathology of dementia and movement disorders. Wiley-Blackwell, City","author":"DW Dickson","year":"2011","unstructured":"Dickson DW, Hauw JJ, Agid Y, Litvan I (2011) Progressive supranuclear palsy and corticobasal degeneration. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders. Wiley-Blackwell, City, pp 135\u2013155 \n                    https:\/\/doi.org\/10.1002\/9781444341256"},{"issue":"17","key":"535_CR9","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.1021\/acs.jmedchem.7b00632","volume":"60","author":"LC Gobbi","year":"2017","unstructured":"Gobbi LC, Knust H, K\u00f6rner M, Honer M, Czech C, Belli S, Muri D, Edelmann MR, Hartung T, Erbsmehl I, Grall-Ulsemer S, Koblet A, Rueher M, Steiner S, Ravert HT, Mathews WB, Holt DP, Kuwabara H, Valentine H, Dannals RF, Wong DF, Borroni E (2017) Identification of three novel radiotracers for imaging aggregated tau in Alzheimer's disease with positron emission tomography. J Med Chem 60(17):7350\u20137370 \n                    https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00632","journal-title":"J Med Chem"},{"issue":"3","key":"535_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0304-3940(95)11484-E","volume":"189","author":"M Goedert","year":"1995","unstructured":"Goedert M, Jakes R, Vanmechelen E (1995) Monoclonal antibody AT8 recognises tau protein phosphorylated AT both serine 202 and threonine 205. Neurosci Lett 189(3):167\u2013169 \n                    https:\/\/doi.org\/10.1016\/0304-3940(95)11484-E","journal-title":"Neurosci Lett"},{"issue":"7","key":"535_CR11","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s00259-015-3035-4","volume":"42","author":"R Harada","year":"2015","unstructured":"Harada R, Okamura N, Furumoto S, Furukawa K, Ishiki A, Tomita N, Hiraoka K, Watanuki S, Shidahara M, Miyake M, Ishikawa Y, Matsuda R, Inami A, Yoshikawa T, Tago T, Funaki Y, Iwata R, Tashiro M, Yanai K, Arai H, Kudo Y (2015) [(18)F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease. Eur J Nucl Med Mol Imaging 42(7):1052\u20131061 \n                    https:\/\/doi.org\/10.1007\/s00259-015-3035-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"535_CR12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2967\/jnumed.115.164848","volume":"57","author":"R Harada","year":"2016","unstructured":"Harada R, Okamura N, Furumoto S, Furukawa K, Ishiki A, Tomita N, Tago T, Hiraoka K, Watanuki S, Shidahara M, Miyake M, Ishikawa Y, Matsuda R, Inami A, Yoshikawa T, Funaki Y, Iwata R, Tashiro M, Yanai K, Arai H, Kudo Y (2016) 18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease. J Nucl Med 57(2):208\u2013214 \n                    https:\/\/doi.org\/10.2967\/jnumed.115.164848","journal-title":"J Nucl Med"},{"issue":"1","key":"535_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/biom6010007","volume":"6","author":"R Harada","year":"2016","unstructured":"Harada R, Okamura N, Furumoto S, Tago T, Yanai K, Arai H, Kudo Y (2016) Characteristics of tau and its ligands in PET imaging. Biomol Ther 6(1):7 \n                    https:\/\/doi.org\/10.3390\/biom6010007","journal-title":"Biomol Ther"},{"issue":"1","key":"535_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2005.11.001","volume":"28","author":"V Haroutunian","year":"2007","unstructured":"Haroutunian V, Davies P, Vianna C, Buxbaum JD, Purohit DP (2007) Tau protein abnormalities associated with the progression of Alzheimer disease type dementia. Neurobiol Aging 28(1):1\u20137 \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.11.001","journal-title":"Neurobiol Aging"},{"issue":"10","key":"535_CR15","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.2967\/jnumed.115.171678","volume":"57","author":"ED Hostetler","year":"2016","unstructured":"Hostetler ED, Walji AM, Zeng Z, Miller P, Bennacef I, Salinas C, Connolly B, Gantert L, Haley H, Holahan M, Purcell M, Riffel K, Lohith TG, Coleman P, Soriano A, Ogawa A, Xu S, Zhang X, Joshi E, Della Rocca J, Hesk D, Schenk DJ, Evelhoch JL (2016) Preclinical characterization of 18F-MK-6240, a promising PET tracer for in vivo quantification of human neurofibrillary tangles. J Nucl Med 57(10):1599\u20131606 \n                    https:\/\/doi.org\/10.2967\/jnumed.115.171678","journal-title":"J Nucl Med"},{"issue":"1","key":"535_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/ene.13164","volume":"24","author":"A Ishiki","year":"2017","unstructured":"Ishiki A, Harada R, Okamura N, Tomita N, Rowe CC, Villemagne VL, Yanai K, Kudo Y, Arai H, Furumoto S, Tashiro M, Furukawa K (2017) Tau imaging with [18F]THK-5351 in progressive supranuclear palsy. Eur J Neurol 24(1):130\u2013136 \n                    https:\/\/doi.org\/10.1111\/ene.13164","journal-title":"Eur J Neurol"},{"issue":"1","key":"535_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"KA Johnson","year":"2016","unstructured":"Johnson KA, Schultz A, Betensky RA, Becker JA, Sepulcre J, Rentz D, Mormino E, Chhatwal J, Amariglio R, Papp K, Marshall G, Albers M, Mauro S, Pepin L, Alverio J, Judge K, Philiossaint M, Shoup T, Yokell D, Dickerson B, Gomez-Isla T, Hyman B, Vasdev N, Sperling R (2016) Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol 79(1):110\u2013119 \n                    https:\/\/doi.org\/10.1002\/ana.24546","journal-title":"Ann Neurol"},{"issue":"4","key":"535_CR18","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.neuron.2016.09.055","volume":"92","author":"SK Kaufman","year":"2016","unstructured":"Kaufman SK, Sanders DW, Thomas TL, Ruchinskas AJ, Vaquer-Alicea J, Sharma AM, Miller TM, Diamond MI (2016) Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo. Neuron 92(4):796\u2013812 \n                    https:\/\/doi.org\/10.1016\/j.neuron.2016.09.055","journal-title":"Neuron"},{"issue":"Pt 9","key":"535_CR19","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1093\/brain\/awr160","volume":"134","author":"T Lashley","year":"2011","unstructured":"Lashley T, Rohrer JD, Bandopadhyay R, Fry C, Ahmed Z, Isaacs AM, Brelstaff JH, Borroni B, Warren JD, Troakes C, King A, Al-Saraj S, Newcombe J, Quinn N, Ostergaard K, Schr\u00f8der HD, Bojsen-M\u00f8ller M, Braendgaard H, Fox NC, Rossor MN, Lees AJ, Holton JL, Revesz T (2011) A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. Brain 134(Pt 9):2548\u20132564 \n                    https:\/\/doi.org\/10.1093\/brain\/awr160","journal-title":"Brain"},{"key":"535_CR20","doi-asserted-by":"publisher","unstructured":"Lemoine L, Saint-Aubert L, Marutle A, Antoni G, Eriksson JP, Ghetti B, Okamura N, Nennesmo I, Gillberg PG, Nordberg A (2015) Visualization of regional tau deposits using 3H-THK5117 in Alzheimer brain tissue. Acta Neuropathol Commun 3(40) \n                    https:\/\/doi.org\/10.1186\/s40478-015-0220-4","DOI":"10.1186\/s40478-015-0220-4"},{"issue":"6","key":"535_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158460","volume":"11","author":"SN Lockhart","year":"2016","unstructured":"Lockhart SN, Baker SL, Okamura N, Furukawa K, Ishiki A, Furumoto S, Tashiro M, Yanai K, Arai H, Kudo Y, Harada R, Tomita N, Hiraoka K, Watanuki S, Jagust WJ (2016) Dynamic PET measures of tau accumulation in cognitively normal older adults and Alzheimer's disease patients measured using [18F]THK-5351. PLoS One 11(6):e0158460 \n                    https:\/\/doi.org\/10.1371\/journal.pone.0158460","journal-title":"PLoS One"},{"issue":"1","key":"535_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","volume":"4","author":"VJ Lowe","year":"2016","unstructured":"Lowe VJ, Curran G, Fang P, Liesinger AM, Josephs KA, Parisi JE, Kantarci K, Boeve BF, Pandey MK, Bruinsma T, Knopman DS, Jones DT, Petrucelli L, Cook CN, Graff-Radford NR, Dickson DW, Petersen RC, Jack CR Jr, Murray ME (2016) An autoradiographic evaluation of AV-1451 tau PET in dementia. Acta Neuropathol Commun 4(1):58 \n                    https:\/\/doi.org\/10.1186\/s40478-016-0315-6","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"535_CR23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ana.24517","volume":"78","author":"M Marqui\u00e9","year":"2015","unstructured":"Marqui\u00e9 M, Normandin MD, Vanderburg CR, Costantino IM, Bien EA, Rycyna LG, Klunk WE, Mathis CA, Ikonomovic MD, Debnath ML, Vasdev N, Dickerson BC, Gomperts SN, Growdon JH, Johnson KA, Frosch MP, Hyman BT, G\u00f3mez-Isla T (2015) Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol 78(5):787\u2013800 \n                    https:\/\/doi.org\/10.1002\/ana.24517","journal-title":"Ann Neurol"},{"issue":"1","key":"535_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/ana.24844","volume":"81","author":"M Marqui\u00e9","year":"2017","unstructured":"Marqui\u00e9 M, Normandin MD, Meltzer AC, Siao Tick Chong M, Andrea NV, Ant\u00f3n-Fern\u00e1ndez A, Klunk WE, Mathis CA, Ikonomovic MD, Debnath M, Bien EA, Vanderburg CR, Costantino I, Makaretz S, DeVos SL, Oakley DH, Gomperts SN, Growdon JH, Domoto-Reilly K, Lucente D, Dickerson BC, Frosch MP, Hyman BT, Johnson KA, G\u00f3mez-Isla T (2017) Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies. Ann Neurol 81(1):117\u2013128 \n                    https:\/\/doi.org\/10.1002\/ana.24844","journal-title":"Ann Neurol"},{"issue":"4","key":"535_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L, neurologists p CERAD (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41(4):479\u2013486 \n                    https:\/\/doi.org\/10.1212\/WNL.41.4.479","journal-title":"Neurology"},{"issue":"1","key":"535_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT, National Institute on Aging; Alzheimer\u2019s Association (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 123(1):1\u201311 \n                    https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"issue":"47","key":"535_CR27","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.1523\/JNEUROSCI.1230-17.2017","volume":"37","author":"S Narasimhan","year":"2017","unstructured":"Narasimhan S, Guo JL, Changolkar L, Stieber A, McBride JD, Silva LV, He Z, Zhang B, Gathagan RJ, Trojanowski JQ, Lee VMY (2017) Pathological tau strains from human brains recapitulate the diversity of tauopathies in nontransgenic mouse brain. J Neurosci 37(47):11406\u201311423 \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1230-17.2017","journal-title":"J Neurosci"},{"issue":"1","key":"535_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","volume":"9","author":"KP Ng","year":"2017","unstructured":"Ng KP, Pascoal TA, Mathotaarachchi S, Therriault J, Kang MS, Shin M, Guiot MC, Guo Q, Harada R, Comley RA, Massarweh G, Soucy JP, Okamura N, Gauthier S, Rosa-Neto P (2017) Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain. Alzheimers Res Ther 9(1):25 \n                    https:\/\/doi.org\/10.1186\/s13195-017-0253-y","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"535_CR29","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.2967\/jnumed.112.117341","volume":"54","author":"N Okamura","year":"2013","unstructured":"Okamura N, Furumoto S, Harada R, Tago T, Yoshikawa T, Fodero-Tavoletti M, Mulligan RS, Villemagne VL, Akatsu H, Yamamoto T, Arai H, Iwata R, Yanai K, Kudo Y (2013) Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease. J Nucl Med 54(8):1420\u20131427 \n                    https:\/\/doi.org\/10.2967\/jnumed.112.117341","journal-title":"J Nucl Med"},{"issue":"11","key":"535_CR30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s11910-014-0500-6","volume":"14","author":"N Okamura","year":"2014","unstructured":"Okamura N, Harada R, Furumoto S, Arai H, Yanai K, Kudo Y (2014) Tau PET imaging in Alzheimer's disease. Curr Neurol Neurosci Rep 14(11):500 \n                    https:\/\/doi.org\/10.1007\/s11910-014-0500-6","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"535_CR31","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/brain\/aww339","volume":"140","author":"M Ono","year":"2017","unstructured":"Ono M, Sahara N, Kumata K, Ji B, Ni R, Koga S, Dickson DW, Trojanowski JQ, Lee VM, Yoshida M, Hozumi I, Yoshiyama Y, van Swieten JC, Nordberg A, Suhara T, Zhang MR, Higuchi M (2017) Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies. Brain 140(3):764\u2013780 \n                    https:\/\/doi.org\/10.1093\/brain\/aww339","journal-title":"Brain"},{"issue":"Pt 5","key":"535_CR32","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Sch\u00f6ll M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, Kramer JH, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD (2016) Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain 139(Pt 5):1551\u20131567 \n                    https:\/\/doi.org\/10.1093\/brain\/aww027","journal-title":"Brain"},{"issue":"3","key":"535_CR33","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/brain\/aww340","volume":"140","author":"L Passamonti","year":"2017","unstructured":"Passamonti L, V\u00e1zquez Rodr\u00edguez P, Hong YT, Allinson KS, Williamson D, Borchert RJ, Sami S, Cope TE, Bevan-Jones WR, Jones PS, Arnold R, Surendranathan A, Mak E, Su L, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB (2017) 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy. Brain 140(3):781\u2013791 \n                    https:\/\/doi.org\/10.1093\/brain\/aww340","journal-title":"Brain"},{"key":"535_CR34","doi-asserted-by":"publisher","unstructured":"Phillips JS, Das SR, McMillan CT, Irwin DJ, Roll EE, Da Re F, Nasrallah IM, Wolk DA, Grossman M (2017) Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease. Hum Brain Mapp:1\u201318 \n                    https:\/\/doi.org\/10.1002\/hbm.23874","DOI":"10.1002\/hbm.23874"},{"key":"535_CR35","doi-asserted-by":"publisher","unstructured":"Pontecorvo MJ, Devous MD Sr, Navitsky M, Lu M, Salloway S, Schaerf FW, Jennings D, Arora AK, McGeehan A, Lim NC, Xiong H, Joshi AD, Siderowf A, Mintun MA; 18F-AV-1451-A05 investigators (2017) Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Brain 140 (3): 748\u2013763. \n                    https:\/\/doi.org\/10.1093\/brain\/aww334","DOI":"10.1093\/brain\/aww334"},{"issue":"1","key":"535_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-017-0162-3","volume":"12","author":"L Saint-Aubert","year":"2017","unstructured":"Saint-Aubert L, Lemoine L, Chiotis K, Leuzy A, Rodriguez-Vieitez E, Nordberg A (2017) Tau PET imaging: present and future directions. Mol Neurodegener 12(1):19 \n                    https:\/\/doi.org\/10.1186\/s13024-017-0162-3","journal-title":"Mol Neurodegener"},{"issue":"11","key":"535_CR37","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jalz.2016.01.003","volume":"12","author":"K Sander","year":"2016","unstructured":"Sander K, Lashley T, Gami P, Gendron T, Lythgoe MF, Rohrer JD, Schott JM, Revesz T, Fox NC, \u00c5rstad E (2016) Characterization of tau positron emission tomography tracer [18F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias. Alzheimers Dement 12(11):1116\u20131124 \n                    https:\/\/doi.org\/10.1016\/j.jalz.2016.01.003","journal-title":"Alzheimers Dement"},{"issue":"7","key":"535_CR38","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Meth 9(7):671\u2013675 \n                    https:\/\/doi.org\/10.1038\/nmeth.2089","journal-title":"Nat Meth"},{"issue":"5","key":"535_CR39","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll M, Lockhart SN, Schonhaut DR, O'Neil JP, Janabi M, Ossenkoppele R, Baker SL, Vogel JW, Faria J, Schwimmer HD, Rabinovici GD, Jagust WJ (2016) PET imaging of tau deposition in the aging human brain. Neuron 89(5):971\u2013982 \n                    https:\/\/doi.org\/10.1016\/j.neuron.2016.01.028","journal-title":"Neuron"},{"key":"535_CR40","doi-asserted-by":"publisher","unstructured":"Schwarz AJ, Yu P, Miller BB, Shcherbinin S, Dickson J, Navitsky M, Joshi AD, Devous MD Sr, Mintun MS (2016) Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages. Brain 139: 1539\u20131550. \n                    https:\/\/doi.org\/10.1093\/brain\/aww023","DOI":"10.1093\/brain\/aww023"},{"key":"535_CR41","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1093\/brain\/aww163","volume":"139","author":"R Smith","year":"2016","unstructured":"Smith R, Puschmann A, Sch\u00f6ll M, Ohlsson T, van Swieten J, Honer M, Englund E, Hansson O (2016) 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers. Brain 139:2372\u20132379 \n                    https:\/\/doi.org\/10.1093\/brain\/aww163","journal-title":"Brain"},{"issue":"8","key":"535_CR42","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1212\/WNL.0000000000003636","volume":"88","author":"S Spina","year":"2017","unstructured":"Spina S, Schonhaut DR, Boeve BF, Seeley WW, Ossenkoppele R, O'Neil JP, Lazaris A, Rosen HJ, Boxer AL, Perry DC, Miller BL, Dickson DW, Parisi JE, Jagust WJ, Murray ME, Rabinovici GD (2017) Frontotemporal dementia with the V337M MAPT mutation: tau-PET and pathology correlations. Neurology 88(8):758\u2013766 \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000003636","journal-title":"Neurology"},{"key":"535_CR43","unstructured":"Szardenings AK, Kolb HC, Walsh JC, Chen G, Gangadharmath UB, Kasi D, Liu C, Sinha A, Wang E, Yu C, Zhang W, Chen K, Mocharla VP, Scott PJH (2012) Imaging agents for detecting neurological dysfunction. Patent Application US20120302755 A1 (Siemens Medical Solutions USA, Inc.)"},{"issue":"12","key":"535_CR44","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2000","unstructured":"Thal DR, Rueb U, Orantes M, Braak H (2000) Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology 58(12):1791\u20131800 \n                    https:\/\/doi.org\/10.1212\/WNL.58.12.1791","journal-title":"Neurology"},{"issue":"6","key":"535_CR45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s004010000306","volume":"101","author":"T Uchihara","year":"2001","unstructured":"Uchihara T, Nakamura A, Yamazaki M (2001) Mori O (2001) evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence. Acta Neuropathol 101(6):535\u2013539 \n                    https:\/\/doi.org\/10.1007\/s004010000306","journal-title":"Acta Neuropathol"},{"issue":"2","key":"535_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/mds.27271","volume":"33","author":"C Vermeiren","year":"2018","unstructured":"Vermeiren C, Motte P, Viot D, Mairet-Coello G, Courade JP, Citron M, Mercier J, Hannestad J, Gillard M (2018) The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases. Mov Disord 33(2):273\u2013281 \n                    https:\/\/doi.org\/10.1002\/mds.27271","journal-title":"Mov Disord"},{"key":"535_CR47","unstructured":"Vettermann F, Brendel M, Schaenecker S, Haeglinger G, Danek A, Levin J, Bartenstein P, Okamura N, Rominger A (2016) [18F]THK-5351 PET in patients with clinically diagnosed progressive supranuclear palsy. J Nucl Med 57 (supplement 2): 457"},{"key":"535_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17:5\u201321 \n                    https:\/\/doi.org\/10.1038\/nrn.2015.1","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"535_CR49","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","volume":"9","author":"CF Xia","year":"2013","unstructured":"Xia CF, Arteaga J, Chen G, Gangadharmath U, Gomez LF, Kasi D, Lam C, Liang Q, Liu C, Mocharla VP, Mu F, Sinha A, Su H, Szardenings AK, Walsh JC, Wang E, Yu C, Zhang W, Zhao T, Kolb HC (2013) [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease. Alzheimers Dement 9(6):666\u2013676 \n                    https:\/\/doi.org\/10.1016\/j.jalz.2012.11.008","journal-title":"Alzheimers Dement"},{"issue":"3","key":"535_CR50","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3233\/JAD-2012-120712","volume":"31","author":"W Zhang","year":"2012","unstructured":"Zhang W, Arteaga J, Cashion DK, Chen G, Gangadharmath U, Gomez LF, Kasi D, Lam C, Liang Q, Liu C, Mocharla VP, Mu F, Sinha A, Szardenings AK, Wang E, Walsh JC, Xia C, Yu C, Zhao T, Kolb HC (2012) A highly selective and specific PET tracer for imaging of tau pathologies. J Alzheimers Dis 31(3):601\u2013612 \n                    https:\/\/doi.org\/10.3233\/JAD-2012-120712","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"535_CR51","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/nn.4025","volume":"18","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Sagare AP, Ma Q, Halliday MR, Kong P, Kisler K, Winkler EA, Ramanathan A, Kanekiyo T, Bu G, Owens NC, Rege SV, Si G, Ahuja A, Zhu D, Miller CA, Schneider JA, Maeda M, Maeda T, Sugawara T, Ichida JK, Zlokovic BV (2015) Central role for PICALM in amyloid-\u03b2 blood-brain barrier transcytosis and clearance. Nat Neurosci 18(7):978\u2013987 \n                    https:\/\/doi.org\/10.1038\/nn.4025","journal-title":"Nat Neurosci"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0535-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-018-0535-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0535-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T20:13:52Z","timestamp":1556655232000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-018-0535-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["535"],"URL":"https:\/\/doi.org\/10.1186\/s40478-018-0535-z","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,1]]},"assertion":[{"value":"13 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for the collection of post-mortem human brain tissue was obtained by the Queen Square Brain Bank for Neurological Disorders from the National Research Ethics Service Committee London (Central: 08\/H0718\/54\u2009+\u20095). No personalised consent for publication was obtained as cases were anonymised for the purposes of reporting the results of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"34"}}